Stay updated with breaking news from Bharat Biocon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
With healthcare infrastructure still in shambles and an ill-prepared administration, it is still an uphill battle for India; Omicron and other variants will only add to our woes
Efficacy report pending, yet government greenlights use of indigenously developed Covaxin Sabrangindia16 Jan 2021 Even as India kickstarts its nationwide Covid vaccination campaign, a new controversy has erupted over the approval to use Bharat Biotech’s indigenously developed Covaxin, whose efficacy data is still awaited. Concerns are being raised about granting emergency use authorisation to Covaxin, an indigenously developed vaccine manufactured by Bharat Biocon, even though the third phase of its trial isn’t completed and its efficacy data is not yet available. In f...